Additionally, ANGPTL4 p.Cys80fs was associated with a decreased risk of two T2D-related outcomes and a lowered probability of statin prescription and hypercholesterolaemia diagnosis (Figure 4D). The gene discussed is ANGPTL4; the disease is Hypercholesterolemia.